K

Kimberly-Clark

Global maker of personal care products

Overview

Kimberly-Clark makes and sells everyday hygiene and personal care products worldwide, including Kleenex tissues, Huggies diapers, Scott paper products, Kotex feminine care, and Depend incontinence products, plus workplace solutions through K-C Professional. Products are produced at large-scale manufacturing facilities and sold through retailers to consumers, as well as to businesses and healthcare facilities. It differentiates itself with a global brand portfolio, wide distribution, and a commitment to sustainability and social impact. Its goal is to provide essential hygiene products at scale while advancing ESG initiatives, such as renewable energy use and sanitation programs.

Funded Recently

Work here?Claim your company

About Kimberly-Clark

Simplify's Rating
Why Kimberly-Clark is rated
C+
Rated B on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

HealthcareConsumer Goods

Company Size

10,001+

Company Stage

IPO

Headquarters

Irving, TX

Founded

1871

Get referred to Kimberly-Clark

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • October 1, 2026 leadership reset assigns synergy delivery to CFO Nelson Urdaneta.
  • August 4, 2026 results delivered 0.6% sales growth and mid-single-digit operating profit growth.
  • Barrow FID on May 20, 2026 advances lower-cost energy and supply-chain resilience.

What critics are saying

  • Reuters on September 23, 2026 showed EU regulators demanding Kenvue divestitures.
  • August 4, 2026 China diaper rumors cut 2026 sales growth and profits.
  • 2025 free cash flow missed dividends; Kenvue financing can overwhelm balance-sheet flexibility.

What makes Kimberly-Clark unique

  • Kimberly-Clark owns Huggies, Kleenex, Scott, Kotex, and Depend across 175 countries.
  • Barrow-in-Furness hydrogen project cuts natural gas 50% and 18,300 tonnes CO2.
  • Its Kenvue merger creates a $32 billion consumer-health platform with 10 billion-dollar brands.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$4.9B

Above

Industry Average

Funded Over

2 Rounds

Post IPO Debt funding comparison data is currently unavailable. We're working to provide this information soon!
Post IPO Debt Funding Comparison Coming Soon

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Health Savings Account/Flexible Spending Account
  • Hybrid Work Options
  • 401(k) Company Match
  • Profit Sharing
  • Relocation Assistance
  • Adoption Assistance
  • Tuition Reimbursement

Stock Price

Company News

Yahoo Finance
Nov 8th, 2026
Kimberly-Clark's dividend is up 392% since 1999, but its $49B Kenvue deal tests the streak

Kimberly-Clark has raised its dividend for 54 straight years, lifting the quarterly payout from $0.26 in 1999 to $1.28, up about 392%. The company now faces its biggest test in decades after closing a $49 billion acquisition of Kenvue on November 2, 2026. Cash cover is thin. Dividends cost $1.66 billion in 2025, against free cash flow of $1.64 billion. The latest raise, from $1.26 to $1.28, was about 1.6%. Management expects mid-single-digit adjusted earnings per share dilution in the first full year, targets about $1.9 billion in cost synergies, and aims for roughly two times leverage by the end of the deal's second year. The deal was funded partly by a $4.9 billion senior notes offering. The company plans to give its full outlook in February.

Business Insider
Nov 7th, 2026
Kimberly Clark (KMB) receives a Buy from Bank of America Securities.

Kimberly Clark (KMB) receives a Buy from Bank of America Securities. Nov. 7, 2026, 12:36 AM Bank of America Securities analyst Anna Lizzul maintained a Buy rating on Kimberly Clark yesterday. The company's shares closed yesterday at $108.43. Lizzul covers the Consumer Defensive sector, focusing on stocks such as Clorox, Kimberly Clark, and e.l.f. Beauty. According to TipRanks, Lizzul has an average return of 0.0% and a 47.48% success rate on recommended stocks. In addition to Bank of America Securities, Kimberly Clark also received a Buy from Piper Sandler's Michael Lavery in a report issued yesterday. However, on the same day, UBS maintained a Hold rating on Kimberly Clark (NASDAQ: KMB). Based on Kimberly Clark's latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $4.13 billion and a net profit of $1.79 billion. In comparison, last year the company earned a revenue of $4.13 billion and had a net profit of $446 million Read More on KMB:

Yahoo Finance
Nov 6th, 2026
Kimberly-Clark vs Lululemon: why the $16.4B defensive stock beats growth for 2027

A Motley Fool columnist picks Kimberly-Clark over Lululemon Athletica as the better consumer goods stock for 2027, citing its defensive profile. Kimberly-Clark, maker of Kleenex and Huggies, posted 2025 revenue of nearly $16.4 billion, down about 2.1%, with net income of roughly $2 billion. It has $956 million in cash and $6.5 billion in debt. The stock yields 4.6%, and the company has raised its dividend for 54 consecutive years. Lululemon's 2025 revenue grew nearly 4.9% to about $11.1 billion, with net income of roughly $1.6 billion. It holds $1.3 billion in cash and $2.1 billion in debt. The columnist notes risks for both: Kimberly-Clark's Kenvue acquisition, and Lululemon's new chief executive officer and trade policy changes.

Yahoo Finance
Nov 5th, 2026
Kimberly-Clark on track for $1.9B Kenvue cost synergies after completing acquisition

Kimberly-Clark has completed its acquisition of Kenvue and says it remains on track to deliver about $1.9 billion in cost synergies, executives said on the third-quarter earnings call. About one-third of the savings should come from overhead, including some role eliminations. Another 30% to 40% should come from cost of goods sold, such as procurement and distribution, with the rest from sales, marketing and trade-spending efficiencies. Chairman and chief executive officer Mike Hsu said the new operating model took effect this week. The first 100 days will focus on keeping operations running and capturing early savings, with growth the aim for 2027. The company expects 2027 adjusted EPS dilution of no more than the mid-single digits, then mid- to high-single-digit EPS growth in 2028 on a two-year compounded basis.

Yahoo Finance
Nov 5th, 2026
ETFs dump $558.4M of Kimberly-Clark, led by SDY, after $2.42B inflow the day before

ETFs were net sellers of Kimberly-Clark (KMB) on Tuesday, pulling out $558.4 million. The SPDR S&P Dividend ETF (SDY) led the selling with $243.7 million, cutting its stake by 45.4%. NOBL sold $131.6 million and SPYD $77.2 million. Overall, 35 ETFs bought shares while 18 sold, but the buyers' amounts were smaller. The outflow followed a $2.42 billion net inflow on November 2. ETFs were net buyers on four of the last five reported days. Kimberly-Clark, maker of Huggies, Kleenex, and Kotex, has a market cap of $66.8 billion. Its shares are up 11.99% this year, with a dividend yield of 4.73%.

Recently Posted Jobs

Sign up to get curated job recommendations

Kimberly-Clark is Hiring for 124 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs